NanoTube: a series of videos on nanotechnologies

NanoDiode, a CSA funded by the European Union under the NMP Cooperation FP7 Work Programme, produced NanoTube, a collection of short videoclips, interviewing specialists around Europe working with nanotechnologies.

Do you want to know how physicists, chemists, toxicologists, philosophers, artists, sociologists, industrials and policy makers think nanotechnologies will impact society? Then check the videoclips here and you will hear about their hopes, dreams, expectations, fears and concerns.

FDA issues final guidance for antibacterial streamlined program

FDA published guidance for companies developing new antibacterial drugs. The guideline presents possible streamlined development programs and clinical trial designs for antibacterial drugs to treat serious bacterial diseases in patients with an unmet medical need, including patients who have a serious bacterial disease for which effective antibacterial drugs are limited or lacking.

Candidates for a streamlined program include, among others, products with an affed inhibitor that neutralize resistance or an alteration in molecule structure that limits reistance.

For more details, guidance are available here.

The new EU One Health Action Plan against Antimicrobial Resistance

In June 2017, the European Commission adopted the new EU One Health Action Plan against AMR. 

The key objectives of this new plan are built on 3 main pillars:

  1. Making the EU a best practice region
  2. Boosting research, development and innovation
  3. Shaping the global agenda

The Commission has also adopted the 1st deliverable of the plan, i.e., the EU Guidelines on the prudent use of antimicrobials in human health.

More information and documents can be found here.

PneumoNP Newsletter - June 2017

The latest trimetrial newsletter from PneumoNP is available.

Read here the latest progress of this project.

Symposium: “Molecular basis of antibiotic permeability in Gram-negative bacteria: Solving a new question within a private-public partnership”

The IMI project Translocation is organising a symposimu entitled “Molecular basis of antibiotic permeability in Gram-negative bacteria: Solving a new question within a private-public partnership” that will take place on 21-23.06.2017 in Helmholtz Centre for Infection Research, Braunschweig, Germany.

More information (including programe and registration links) are avaialble here.



The NAREB project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 604237.